Steinhilber D - Search Results

1

Small molecules with anti-inflammatory properties in clinical development.

Hanke T, Merk D, Steinhilber D, Geisslinger G, Schubert-Zsilavecz M. Hanke T, et al. Among authors: steinhilber d. Pharmacol Ther. 2016 Jan;157:163-87. doi: 10.1016/j.pharmthera.2015.11.011. Epub 2015 Nov 26. Pharmacol Ther. 2016. PMID: 26627986 Review.

2

Boswellic acids activate p42(MAPK) and p38 MAPK and stimulate Ca(2+) mobilization.

Altmann A, Fischer L, Schubert-Zsilavecz M, Steinhilber D, Werz O. Altmann A, et al. Among authors: steinhilber d. Biochem Biophys Res Commun. 2002 Jan 11;290(1):185-90. doi: 10.1006/bbrc.2001.6153. Biochem Biophys Res Commun. 2002. PMID: 11779151

3

Coupling of boswellic acid-induced Ca2+ mobilisation and MAPK activation to lipid metabolism and peroxide formation in human leucocytes.

Altmann A, Poeckel D, Fischer L, Schubert-Zsilavecz M, Steinhilber D, Werz O. Altmann A, et al. Among authors: steinhilber d. Br J Pharmacol. 2004 Jan;141(2):223-32. doi: 10.1038/sj.bjp.0705604. Epub 2003 Dec 22. Br J Pharmacol. 2004. PMID: 14691050 Free PMC article.

4

[Molecular pharmacology and medicinal chemistry of fibrate].

Steinhilber D, Schubert-Zsilavecz M. Steinhilber D, et al. Pharm Unserer Zeit. 2007;36(2):108-12. doi: 10.1002/pauz.200600208. Pharm Unserer Zeit. 2007. PMID: 17424995 Review. German. No abstract available.

5

[New targets and drugs for treatment of lipid metabolism disorders].

Rau O, Zettl H, Popescu L, Steinhilber D, Schubert-Zsilavecz M. Rau O, et al. Among authors: steinhilber d. Pharm Unserer Zeit. 2007;36(2):142-8. doi: 10.1002/pauz.200600213. Pharm Unserer Zeit. 2007. PMID: 17425000 Review. German. No abstract available.

6

The treatment of dyslipidemia--what's left in the pipeline?

Rau O, Zettl H, Popescu L, Steinhilber D, Schubert-Zsilavecz M. Rau O, et al. Among authors: steinhilber d. ChemMedChem. 2008 Feb;3(2):206-21. doi: 10.1002/cmdc.200700165. ChemMedChem. 2008. PMID: 17963209 Review.

7

Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress pro-inflammatory responses of stimulated human polymorphonuclear leukocytes.

Poeckel D, Greiner C, Verhoff M, Rau O, Tausch L, Hörnig C, Steinhilber D, Schubert-Zsilavecz M, Werz O. Poeckel D, et al. Among authors: steinhilber d. Biochem Pharmacol. 2008 Jul 1;76(1):91-7. doi: 10.1016/j.bcp.2008.04.013. Epub 2008 May 1. Biochem Pharmacol. 2008. PMID: 18508031

8

Celecoxib inhibits 5-lipoxygenase.

Maier TJ, Tausch L, Hoernig M, Coste O, Schmidt R, Angioni C, Metzner J, Groesch S, Pergola C, Steinhilber D, Werz O, Geisslinger G. Maier TJ, et al. Among authors: steinhilber d. Biochem Pharmacol. 2008 Oct 1;76(7):862-72. doi: 10.1016/j.bcp.2008.07.009. Epub 2008 Jul 19. Biochem Pharmacol. 2008. PMID: 18692027

9

Novel and potent inhibitors of 5-lipoxygenase product synthesis based on the structure of pirinixic acid.

Werz O, Greiner C, Koeberle A, Hoernig C, George S, Popescu L, Syha I, Schubert-Zsilavecz M, Steinhilber D. Werz O, et al. Among authors: steinhilber d. J Med Chem. 2008 Sep 11;51(17):5449-53. doi: 10.1021/jm800588x. Epub 2008 Aug 19. J Med Chem. 2008. PMID: 18710209

10

Cellular membranes function as a storage compartment for celecoxib.

Maier TJ, Schiffmann S, Wobst I, Birod K, Angioni C, Hoffmann M, Lopez JJ, Glaubitz C, Steinhilber D, Geisslinger G, Grösch S. Maier TJ, et al. Among authors: steinhilber d. J Mol Med (Berl). 2009 Oct;87(10):981-93. doi: 10.1007/s00109-009-0506-8. Epub 2009 Jul 30. J Mol Med (Berl). 2009. PMID: 19641861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page